Biodexa Pharmaceuticals (BDRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Biodexa Pharmaceuticals

    NASDAQ: BDRX · Real-Time Price · USD
    6.70
    0.03 (0.45%)
    At close: Oct 03, 2025, 3:59 PM
    6.81
    1.64%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Biodexa Pharmaceuticals Income Statement

    Financials in GBP. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 n/a n/a 83K 381K 529K 699K 645K 578K 576K
    Cost of Revenue
    		 4.91M 5.44M 4.44M 4.5M 4.95M 5.11M 5.06M 4.65M 5.83M
    Gross Profit
    		 -4.91M -5.44M -4.36M -4.12M -4.42M -4.41M -4.41M -4.08M -5.25M
    Operating Income
    		 -8.99M -9.2M -7.99M -8.01M -8.04M -7.57M -7.54M -7M -9.61M
    Interest Income
    		 n/a 88K 128K 42K 8K 24K 40K 44K 34K
    Pretax Income
    		 -6.52M -5.98M -7.06M -7.49M -8.95M -8.49M -6.11M -6.11M -9M
    Net Income
    		 -6.23M -5.73M -6.82M -7.08M -8.16M -7.66M -5.37M -5.46M -7.92M
    Selling & General & Admin
    		 4.14M 3.79M 2.77M 3.03M 3.62M 3.18M 3.14M 2.95M 4.4M
    Research & Development
    		 4.91M 5.44M 4M 4.07M 4.95M 5.11M 5.06M 4.65M 14.17M
    Other Expenses
    		 -4.97M -3.28M -955K -955K n/a n/a n/a n/a n/a
    Operating Expenses
    		 4.08M 5.95M 5.83M 3.51M 4.52M 4.05M 1.66M 1.99M 3.71M
    Interest Expense
    		 n/a 49K 49K n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a 8K
    Cost & Expenses
    		 8.99M 9.2M 8.08M 8.01M 9.47M 9.16M 6.72M 6.64M 9.54M
    Income Tax Expense
    		 40K -250K -7K 406K 783K 832K 747K 646K 1.08M
    Shares Outstanding (Basic)
    		 2.00 61.95K 2.48K 30.00 7.00 1.00 1.00 1.00 1.00
    Shares Outstanding (Diluted)
    		 2.00 61.95K 2.48K 30.00 7.00 1.00 1.00 1.00 1.00
    EPS (Basic)
    		 -1.87M -1.16M -905K -332K -3.19M -4.94M -3.46M -3.52M -5.12M
    EPS (Diluted)
    		 -1.87M -1.16M -905K -332K -3.19M -4.94M -3.46M -3.52M -5.12M
    EBITDA
    		 -8.87M -8.18M -5.54M -6.46M -7.88M -7.39M -7.35M -6.79M -8.87M
    EBIT
    		 -8.99M -8.36M -5.74M -6.6M -8.04M -7.57M -7.54M -7M -9.61M
    Depreciation & Amortization
    		 120K 185K 209K 146K 154K 177K 192K 213K 742K

    Add to Watchlist